RETRACTION NOTICE: Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke (Journal of Cerebral Blood Flow & Metabolism, (2019), 29, 3, (512-523), 10.1038/jcbfm.2008.140);Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 29, Issue 3, 2009, Pages 512-523

  Ottani, Alessandra ^a   Giuliani, Daniela ^a   Mioni, Chiara ^a   Galantucci, Maria ^a   Minutoli, Letteria ^b   Bitto, Alessandra ^a,b   Altavilla, Domenica ^b   Zaffe, Davide ^a   Botticelli, Annibale R ^c   Squadrito, Francesco ^b   Guarini, Salvatore ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cerebral and systemic damage; Ischemic stroke; Melanocortins; Nicotinic acetylcholine receptors; Vagus nerve

Indexed keywords

ALPHA INTERMEDIN[4 NORLEUCINE 7 DEXTRO PHENYLALANINE]; CASPASE 3; CHLORISONDAMINE; ENDOTHELIN 1; INTERMEDIN; MELANOCORTIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINIC RECEPTOR; NUCLEOSIDE DIPHOSPHATE KINASE A; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHOLINERGIC SYSTEM; CONTROL GROUP; CONTROLLED STUDY; CORPUS STRIATUM; DNA FRAGMENTATION; LIVER; MALE; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; VAGOTOMY; VAGUS NERVE; WESTERN BLOTTING;

EID: 61349113951     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X231154164     Document Type: Erratum

References (40)

1. Adams HP, Del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF (2007) Guidelines for the early management of adults with ischemic stroke. Stroke 38:1655-711
2. Altavilla D, Guarini S, Bitto A, Mioni C, Giuliani D, Bigiani A, Squadrito G, Minutoli L, Venuti FS, Messineo F, De Meo V, Bazzani C, Squadrito F (2006) Activation of the cholinergic anti-inflammatory pathway reduces NF-kB activation, blunts TNF-α production, and protects against splanchnic artery occlusion shock. Shock 25:500-6
3. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W (1996) The p38/ERK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 15:1914-23
4. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-62
5. Borsello T, Clarke PGH, Hirt L, Vercelli A, Repici M, Schorderet DF, Bogousslavsky J, Bonny C (2003) A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med 9:1180-6
6. Braun JS, Prass K, Dirnagl U, Meisel A, Meisel C (2007) Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPH. Exp Neurol 206:183-91
7. Catania A, Gatti S, Colombo G, Lipton JM (2004) Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56:1-29
8. Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA (1999) Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci 2:94-8
9. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of stroke: an integrated view. Trends Neurosci 22:391-7
10. Emsley HCA, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Hallenbeck JM, Del Zoppo GJ, Rothwell NJ, Tyrrell PJ, Hopkins SJ (2003) An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139:93-101
11. Fuxe K, Kurosawa N, Cintra Å, Hallström A, Goiny M, Rosén L, Agnati LF, Ungerstedt U (1992) Involvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anaesthetized rat. Exp Brain Res 88:131-9
12. Gendron A, Teitelbaum J, Cossette C, Nuara S, Dumont M, Geadah D, Du Souich P, Kouassi E (2002) Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res 955:85-97
13. Getting SJ (2006) Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 111:1-15
14. Gill SS, Mueller RW, McGuire PF, Pulido OM (2000) Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity. Toxicol Pathol 28:277-84
15. 7]α-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils. Eur J Pharmacol 538:48-56
16. Giuliani D, Mioni C, Altavilla D, Leone S, Bazzani C, Minutoli L, Bitto A, Cainazzo MM, Marini H, Zaffe D, Botticelli AR, Pizzala R, Savio M, Necchi D, Schiöth HB, Bertolini A, Squadrito F, Guarini S (2006b) Both early and delayed treatment with melanocortin 4 receptorstimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 147:1126-35
17. Giuliani D, Mioni C, Bazzani C, Zaffe D, Botticelli AR, Capolongo S, Sabba A, Galantucci M, Iannone A, Grieco P, Novellino E, Colombo G, Tomasi A, Catania A, Guarini S (2007a) Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage. Br J Pharmacol 150:595-603
18. Giuliani D, Ottani A, Mioni C, Bazzani C, Galantucci M, Minutoli L, Bitto A, Zaffe D, Botticelli AR, Squadrito F, Guarini S (2007b) Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins. Eur J Pharmacol 570:57-65
19. Gladstone DJ, Black SE, Hakim AM (2002) Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33:2123-36
20. Guarini S, Altavilla D, Cainazzo MM, Giuliani D, Bigiani A, Marini H, Squadrito G, Minutoli L, Bertolini A, Marini R, Adamo EB, Venuti FS, Squadrito F (2003) Efferent vagal fibre stimulation blunts NF-kB activation and protects against hypovolemic hemorrhagic shock. Circulation 107:1189-94
21. Guarini S, Bazzani C, Cainazzo MM, Mioni C, Ferrazza G, Vergoni AV, Schiöth HB, Wikberg JE, Bertolini A (1999) Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides. J Pharmacol Exp Ther 291:1023-7
22. Guarini S, Cainazzo MM, Giuliani D, Mioni C, Altavilla D, Marini H, Bigiani A, Ghiaroni V, Passaniti M, Leone S, Bazzani C, Caputi AP, Squadrito F, Bertolini A (2004) Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res 63:357-65
23. Huang Q, Tatro JB (2002) α-Melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-α and interleukin-1β gene expression following transient cerebral ischemia in mice. Neurosci Lett 334:186-90
24. Huh S-K, Lipton JM, Batjer HH (1997) The protective effects of α-melanocyte stimulating hormone on canine brain ischemia. Neurosurgery 40:132-40
25. Leker RR, Shohami E (2002) Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Rev 39:55-73
26. Mioni C, Bazzani C, Giuliani D, Altavilla D, Leone S, Ferrari A, Minutoli L, Bitto A, Marini H, Zaffe D, Botticelli AR, Iannone A, Tomasi A, Bigiani A, Bertolini A, Squadrito F, Guarini S (2005) Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats. Crit Care Med 33:2621-8
27. Mioni C, Giuliani D, Cainazzo MM, Leone S, Iannone C, Bazzani C, Grieco P, Novellino E, Tomasi A, Bertolini A, Guarini S (2003) Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors. Eur J Pharmacol 477:227-34
28. Ni B, Wu X, Su Y, Stephenson D, Smalstig EB, Clemens J, Paul SM (1998) Transient global forebrain ischemia induces a prolonged expression of the caspase-3 mRNA in rat hippocampal CA1 pyramidal neurons. J Cereb Blood Flow Metab 18:248-56
29. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD (2006) Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 26:654-65
30. Ottani A, Saltini S, Bartiromo M, Zaffe D, Botticelli AR, Ferrari A, Bertolini A, Genedani S (2003) Effect of g-hydroxybutyrate in two rat models of focal cerebral damage. Brain Res 986:181-90
31. Pavlov VA, Ochani M, Gallowitsch-Puerta M, Ochani K, Huston JM, Czura CJ, Al-Abed Y, Tracey KJ (2006) Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci USA 103:5219-23
32. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post-stroke T helper cell type 1-like immunostimulation. J Exp Med 198:725-36
33. Smith CJ, Emsley HCA, Gavin CM, Georgiou RF, Vail A, Barberan EM, Del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4:2
34. Spencer SJ, Mouihate A, Pittman QJ (2007) Peripheral inflammation exacerbates damage after global ischemia independently of temperature and acute brain inflammation. Stroke 38:1570-7
35. Tatro JB (2006) Melanocortins defend their territory: multifaceted neuroprotection in cerebral ischemia. Endocrinology 147:1122-5
36. Tracey KJ (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117:289-96
37. Vila N, Castillo J, Dávalos A, Esteve A, Planas AM, Chamorro A (2003) Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 34:671-5
38. Wheless JW, Baumgartner J (2004) Vagus nerve stimulation therapy. Drugs Today 40:501-15
39. Whitehead SN, Hachinski VC, Cechetto DF (2005) Interaction between a rat model of cerebral ischemia and β-amyloid toxicity. Inflammatory responses. Stroke 36:107-12
40. Wikberg JES, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A (2000) New aspects on the melanocortins and their receptors. Pharmacol Res 42:393-420